Clinical Overview

A prolonged P wave is an increase in P-wave duration (width) beyond the normal limit, without necessarily any increase in amplitude — the electrocardiogram’s signature of atrial depolarization taking longer than expected to complete, most often because the depolarizing wavefront’s crossing into or through the left atrium is delayed. It is a P-wave morphology/timing finding, not a rhythm and not itself an anatomic diagnosis. In clinical practice this pattern is called P mitrale when read as suggesting left atrial enlargement or hypertrophy, and interatrial block when the emphasis is on the delayed conduction across the interatrial pathway itself rather than the chamber-size implication — the AHA/ACCF/HRS scientific statement on ECG standardization recommends the broader term “left atrial abnormality” for this class of finding precisely because a P-wave duration criterion does not, on its own, distinguish chamber hypertrophy, chamber dilation, or a pure conduction delay in a normal-sized atrium (Surawicz et al., AHA/ACCF/HRS Scientific Statement, Circulation, 2009). This page covers the ECG sign itself; left atrial hypertrophy and left atrial enlargement are the anatomic diagnoses this pattern can indicate, reported separately in this dataset, and confirming either one requires echocardiography rather than the P-wave duration criteria alone (Parajuli, Alahmadi & Ahmed, StatPearls, 2025).

Mechanistically, the P wave’s early portion is generated by right atrial depolarization, and its middle-to-terminal portion by left atrial depolarization, which begins after the depolarizing impulse crosses the interatrial conduction pathways, principally Bachmann’s bundle (Douedi & Douedi, StatPearls, 2023). When that crossing is delayed — from atrial fibrosis, chronic pressure or volume overload of the left atrium, or age-related degeneration of the conduction tissue — total atrial activation time lengthens and the P wave widens, typically becoming notched or bifid in lead II as the separation between the right- and left-atrial components becomes visible as two distinct peaks, and developing a wider, deeper terminal negative deflection in V1 as the delayed left atrial vector is directed away from that lead (LITFL, P Wave, 2022; LITFL, Left Atrial Enlargement, 2024). This is close to the mechanistic opposite of tall P wave (P pulmonale), where the abnormality amplifies an early right atrial component without lengthening total conduction time, rather than stretching it out (Douedi & Douedi, StatPearls, 2023). The conduction delay itself is graded: partial interatrial block describes delayed but still-complete conduction across Bachmann’s bundle, while advanced interatrial block describes a fuller block that forces the left atrium to activate by an alternate, retrograde route, adding a biphasic (positive-then-negative) shape in the inferior leads (II, III, aVF) on top of the widened duration (Bejarano-Arosemena & Martínez-Sellés, Journal of Clinical Medicine, 2023).

Left atrial pressure or volume overload most often reflects systemic hypertension, mitral valve disease (stenosis or regurgitation), left ventricular hypertrophy, or diastolic dysfunction, and the finding frequently accompanies the ECG voltage criteria for left ventricular hypertrophy given their shared underlying process (Parajuli, Alahmadi & Ahmed, StatPearls, 2025; Left Atrial Enlargement, Cleveland Clinic, reviewed 2022). Clinical weight differs by grade: partial interatrial block is a comparatively minor marker, while advanced interatrial block — the Bayés syndrome pattern — is a marker of atrial fibrosis independently associated with meaningfully increased risk of atrial fibrillation, ischemic stroke, and cognitive decline, a risk that persists whether or not atrial fibrillation has already been documented (Bejarano-Arosemena & Martínez-Sellés, Journal of Clinical Medicine, 2023). ECG duration criteria correlate with true anatomic left atrial enlargement imperfectly enough that echocardiography, which measures left atrial volume directly, remains the reference standard for confirming chamber enlargement (Parajuli, Alahmadi & Ahmed, StatPearls, 2025). In practice this means a prolonged P wave is a reasonable prompt to evaluate for underlying structural heart disease and to watch more closely for atrial fibrillation, particularly when the biphasic inferior-lead pattern of advanced interatrial block is present (LITFL, Left Atrial Enlargement, 2024).

A prolonged P wave itself produces no symptoms — it is a P-wave morphology/timing finding, not a rhythm disturbance, and many patients with it are entirely asymptomatic, with the pattern turning up incidentally on a routine ECG (Left Atrial Enlargement, Cleveland Clinic, reviewed 2022; LITFL, Left Atrial Enlargement, 2024). Any symptoms a patient reports — dyspnea, fatigue, palpitations, chest discomfort, or, when an atrial arrhythmia is already present, symptoms of that arrhythmia — come from the underlying condition driving the left atrial pressure, volume, or conduction disturbance, not from the widened P wave itself (Left Atrial Enlargement, Cleveland Clinic, reviewed 2022).

Causes and risk factors center on whatever raises left atrial pressure or volume, or promotes atrial fibrosis: systemic hypertension and mitral valve disease are the most commonly cited drivers, followed by left ventricular hypertrophy, left ventricular diastolic dysfunction, cardiomyopathy, aortic stenosis, obesity, and advancing age (Parajuli, Alahmadi & Ahmed, StatPearls, 2025; Left Atrial Enlargement, Cleveland Clinic, reviewed 2022; LITFL, Left Atrial Enlargement, 2024). An intensively trained “athlete’s heart” can also produce mild left atrial enlargement and a correspondingly widened P wave as a physiologic adaptation rather than a disease process (Left Atrial Enlargement, Cleveland Clinic, reviewed 2022).

Interpretation Guide

Key Features:

• Rate: not a defining feature — a prolonged P wave is a P-wave morphology/timing finding superimposed on whatever the underlying rate happens to be; in this dataset it is recorded more often alongside sinus tachycardia (roughly 46% of matching records) and sinus bradycardia (roughly 36%) than sinus rhythm (roughly 11%), though that reflects this dataset’s population rather than any rate requirement of the finding itself (search-index.json record data, this dataset)
• Rhythm: not a defining feature — the finding describes P-wave duration, not rhythm origin or regularity
• P waves: the defining feature — duration exceeding 120 ms in lead II, typically with a notched or bifid shape and a peak-to-peak interval between the two peaks exceeding 40 ms, plus a widened (>40 ms) and deepened (>1 mm) terminal negative deflection in V1, sometimes summarized as the “Morris index” (negative-deflection duration times depth exceeding 40 ms·mm) (LITFL, P Wave, 2022; LITFL, Left Atrial Enlargement, 2024; EMCrit IBCC, P-wave Abnormalities, 2024); amplitude stays within the normal range, which is what separates this finding from tall P wave (P pulmonale)
• PR interval: within normal limits (0.12-0.20 s) unless a separate, coexisting conduction disturbance is present
• QRS complex: within normal limits unless left ventricular hypertrophy or another coexisting conduction abnormality is also present — left ventricular hypertrophy voltage criteria accompany this pattern in a meaningful minority of this dataset’s matching records, consistent with their shared underlying causes, but neither is required to call a prolonged P wave (search-index.json record data, this dataset)
• ST segment: within normal limits; not a defining feature of this finding
• T waves: within normal limits; not a defining feature of this finding
• QT interval: within normal limits; not a defining feature of this finding
• Other findings: check the inferior leads (II, III, aVF) for an added biphasic (positive-then-negative) component — its presence marks advanced interatrial block (the Bayés syndrome pattern) rather than the milder partial form, a distinction that changes the finding’s atrial fibrillation and stroke risk (Bejarano-Arosemena & Martínez-Sellés, Journal of Clinical Medicine, 2023); confirm P-wave amplitude stays normal, since an increase in amplitude alongside the widened duration points instead to a combined amplitude-and-duration (biatrial) abnormality rather than a pure prolonged P wave

The defining feature, at any cause, is duration without amplitude: the P wave grows wide and often notched while its height stays within the normal range, which is what separates this finding mechanistically from the amplitude-based tall P wave (P pulmonale) pattern.

Key Leads

• Lead II – Primary lead for diagnosis; the duration (>120 ms) and notched/bifid morphology criteria are assessed here
• Lead V1 – Assesses the P wave’s terminal, left-atrial component; a widened and deepened terminal negative deflection is central to identifying this finding
• Leads III, aVF – Along with lead II, used to check for the added biphasic morphology that distinguishes advanced interatrial block from the milder partial form

Differential Diagnosis

• Left Atrial Hypertrophy (LAH) — the anatomic/structural diagnosis this ECG sign is often presumed to indicate; the same P-wave duration criteria are used for both, so the strip alone cannot confirm true hypertrophy without imaging correlation
• Left Atrial Enlargement (LAE) — this dataset’s separate label for left atrial chamber dilation; it shares the identical P-wave duration criteria with prolonged P wave and left atrial hypertrophy, so a strip’s label among these three cannot be distinguished from the ECG appearance alone
• Tall P Wave (TPW / P pulmonale) — increases P-wave amplitude without lengthening its duration, the mechanistic counterpart of this finding; height versus duration is the discriminator, and in this dataset the two labels essentially never co-occur (1 of 106 records carrying a prolonged P wave also carries tall P wave)
• P Wave Change (PWC) — this dataset’s broader bucket label for any P-wave morphology change, including flattening, notching, or biphasic change without a specified direction; PWC and prolonged P wave never co-occur in this dataset’s records, so a PWC label does not by itself indicate the duration increase that specifically defines a prolonged P wave

Treatment Brief

A prolonged P wave itself needs no direct treatment — it is a P-wave finding, not a disease, and management targets whatever is driving the underlying left atrial pressure, volume, or conduction disturbance.

• Confirm lead placement and calibration, and repeat the strip if the pattern is new or unexpected, before accepting the duration measurement.
• Compare against a prior ECG when available — a longstanding, unchanged pattern in an asymptomatic patient is reassuring, while a new one warrants further evaluation.
• Check the inferior leads specifically for the added biphasic component that marks advanced interatrial block (the Bayés syndrome pattern) — its presence carries a materially higher atrial fibrillation and stroke risk than the partial form and is worth flagging distinctly.
• Correlate clinically, and with echocardiography when the finding is new or otherwise unexplained, rather than treating the ECG duration criteria as confirmation of true anatomic left atrial enlargement.
• Evaluate for an underlying driver: blood pressure control and hypertension workup, mitral valve evaluation, assessment for left ventricular hypertrophy or diastolic dysfunction, and review of cardiomyopathy history where relevant.
• Watch for and report new atrial arrhythmias — the same left atrial disease process that produces this pattern is a recognized substrate for atrial fibrillation, particularly when the advanced, biphasic pattern is present.
• A prolonged P wave found incidentally in an intensively trained athlete, without other new findings, is often a benign physiologic adaptation rather than pathology, though comparison with a prior ECG and clinical correlation remain reasonable.